A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.